Brigit Biofarmaka Teknologi Tbk. vs Nusantara Inti Corpora Tbk — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Nusantara Inti Corpora Tbk trades at Rp316 (market cap 23.83B). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 7× Nusantara Inti Corpora Tbk's market cap. Which is the better fit depends on your goals.
| OBAT | UNIT | |
|---|---|---|
Market Cap | 166.01B | 23.83B |
Volume | 324K | — |
Lot | 3.24K | — |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →Established in Jakarta on 1988 named PT. Aneka Keloladana. On July 2001 changed the name to PT. United Capital Indonesia. Beside as broker dealer in Capital Market, the corporate also provide the services such as financial advisory, research. Average employees are 28 staffs.On July 06 2007, PT United Capital Indonesia Tbk has changed its name as PT Nusantara Inti Corpora Tbk.
Read more on UNIT →